Pharmaceutical policy -- Canada. : Ideas and the pace of change : national pharmaceutical insurance in Canada, Australia, and the United Kingdom / Katherine Boothe
Pharmaceutical policy -- Congresses. : Summary and recommendations / Dept. of Health and Family Services ... in collaboration with the World Health Organization Action Program on Essential Drugs
Pharmaceutical policy -- Jordan. : Measuring transparency to improve good governance in the public pharmaceutical sector. Jordan / World Health Organization, Regional Office for the Eastern Mediterranean
2009
1
Pharmaceutical policy -- Latin America. : Balancing wealth and health : the battle over intellectual property and access to medicines in Latin America / Rochelle Dreyfuss and César Rodríguez-Garavito
2014
1
Pharmaceutical policy -- Lebanon. : Measuring transparency to improve good governance in the public pharmaceutical sector. Lebanon / World Health Organization, Regional Office for the Eastern Mediterranean
Pharmaceutical policy -- United States -- Congresses. : The safe use initiative and health literacy : workshop summary / Cori Vancheri, rapporteur ; Roundtable on Health Literacy, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
2010?
1
Pharmaceutical policy -- United States -- Decision making -- Congresses. : Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products : workshop summary / Denise Caruso, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Pharmaceutical policy -- United States -- Regulations -- Congresses. : Strengthening a workforce for innovative regulatory science in therapeutics development : workshop summary / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals
